Due to the high expression of CD24 in tumor cells and its close association with mechanisms of resistance to radiochemotherapy, targeting CD24 can precisely deliver cancer cell killing and suppress the emergence of chemoradiotherapy resistance. Here, CD24 is linked to cancer.